Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...

Key Takeaways GLP-1 drugs might help a kidney transplant succeedPeople taking the drugs had a lower risk of organ failure and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

The GLP-1 liraglutide showed potential benefit in reducing ... prospective trial designed to evaluate the efficacy and safety of liraglutide (Victoza/Saxenda, Novo Nordisk) for the prevention ...

China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting "good momentum" for its already-approved Victoza, and its successor semaglutide.

Novo's Victoza (liraglutide) daily GLP-1 is already well established and the company hopes to build on its success with semaglutide and its more convenient weekly dosing schedule. Novo is also ...